Open Menu Close Menu

For highly qualified investigators who have shown a capacity for independent, sustained original investigation in the field of leukemia, lymphoma, and myeloma. These scholars are expected to hold independent faculty-level or equivalent positions and have obtained substantial support for their research from a national agency.